Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-04-27

Clinical Trial Update: Bioequivalence Between Integrated E-TRANS (Fentanyl) System and Separated (Two-Part) E-TRANS (Fentanyl) System [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing integrated E-TRANS fentanyl delivery system with a two-part E-TRANS fentanyl system in postoperative pain has been comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENTANYL (FENTANYL)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Pain, Postoperative | Phase 1 | Status: COMPLETED